Given that BAT is highly associated with improved glucose tolerance and insulin sensitivity119, one could envision a personalized treatment developed for patients with cancer and obesity, whereby AMT is used not only to target cancer and its unique metabolism but also to treat the patients’ metabolic disease. This evidence concerns the gene INS and Other metabolic disease.